These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30123000)

  • 1. Adjuvant chemotherapy for stage II colon cancer: who really needs it.
    Yang Y; Yang Y; Yang H; Wang F; Wang H; Chen Q; Liu Y; Li A; Zhang Q
    Cancer Manag Res; 2018; 10():2509-2520. PubMed ID: 30123000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant chemotherapy for stage II colon cancer with poor prognostic features.
    O'Connor ES; Greenblatt DY; LoConte NK; Gangnon RE; Liou JI; Heise CP; Smith MA
    J Clin Oncol; 2011 Sep; 29(25):3381-8. PubMed ID: 21788561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant chemotherapy use for Medicare beneficiaries with stage II colon cancer.
    Schrag D; Rifas-Shiman S; Saltz L; Bach PB; Begg CB
    J Clin Oncol; 2002 Oct; 20(19):3999-4005. PubMed ID: 12351597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omission of Adjuvant Chemotherapy Is Associated With Increased Mortality in Patients With T3N0 Colon Cancer With Inadequate Lymph Node Harvest.
    Wells KO; Hawkins AT; Krishnamurthy DM; Dharmarajan S; Glasgow SC; Hunt SR; Mutch MG; Wise P; Silviera ML
    Dis Colon Rectum; 2017 Jan; 60(1):15-21. PubMed ID: 27926553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant chemotherapy is associated with improved survival in patients with stage II colon cancer.
    Casadaban L; Rauscher G; Aklilu M; Villenes D; Freels S; Maker AV
    Cancer; 2016 Nov; 122(21):3277-3287. PubMed ID: 27417445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospital lymph node examination rates and survival after resection for colon cancer.
    Wong SL; Ji H; Hollenbeck BK; Morris AM; Baser O; Birkmeyer JD
    JAMA; 2007 Nov; 298(18):2149-54. PubMed ID: 18000198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
    Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of Tumor Deposits on Oncologic Outcomes in Stage III Colon Cancer.
    Wong-Chong N; Motl J; Hwang G; Nassif GJ; Albert MR; Monson JRT; Lee L
    Dis Colon Rectum; 2018 Sep; 61(9):1043-1052. PubMed ID: 30086053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors of overall survival for patients with stage II colon cancer.
    Trivedi H; Chamarthy U; Dicarlo L; Herman J; Srkalovic G
    Acta Med Acad; 2014; 43(2):134-43. PubMed ID: 25529518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization and impact of adjuvant chemotherapy among patients with resected stage II colon cancer: a multi-institutional analysis.
    Ejaz A; Casadaban L; Maker AV
    J Surg Res; 2017 Jul; 215():12-20. PubMed ID: 28688636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant chemotherapy is not associated with improved survival for all high-risk factors in stage II colon cancer.
    Verhoeff SR; van Erning FN; Lemmens VE; de Wilt JH; Pruijt JF
    Int J Cancer; 2016 Jul; 139(1):187-93. PubMed ID: 26914273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The re-evaluation of optimal lymph node yield in stage II right-sided colon cancer: is a minimum of 12 lymph nodes adequate?
    Cai Y; Cheng G; Lu X; Ju H; Zhu X
    Int J Colorectal Dis; 2020 Apr; 35(4):623-631. PubMed ID: 31996986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of High-Risk Pathological Factors and their Interaction on the Survival Benefit of Adjuvant Chemotherapy in Stage II Rectal Cancer: A Retrospective Study.
    Zhao K; Li H; Pang W; Zhao X; Zhang B; Fen Z; Jin L; Xue J; Chu T; Yan S; Wang W; Han Q; Yao Y; Zhang X; Su X; Zhang C
    J Cancer; 2024; 15(11):3531-3538. PubMed ID: 38817859
    [No Abstract]   [Full Text] [Related]  

  • 14. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089.
    Le Voyer TE; Sigurdson ER; Hanlon AL; Mayer RJ; Macdonald JS; Catalano PJ; Haller DG
    J Clin Oncol; 2003 Aug; 21(15):2912-9. PubMed ID: 12885809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of various prognostic nodal factors, adjuvant chemotherapy and survival among stage III colon cancer patients over 65 years: an analysis using surveillance, epidemiology and end results (SEER)-Medicare data.
    Hanna NN; Onukwugha E; Choti MA; Davidoff AJ; Zuckerman IH; Hsu VD; Mullins CD
    Colorectal Dis; 2012 Jan; 14(1):48-55. PubMed ID: 21689262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A multi-center retrospective study of perioperative chemotherapy for gastric cancer based on real-world data].
    Ding XW; Zheng ZC; Zhao Q; Zhai G; Liang H; Wu X; Zhu ZG; Wang HJ; He QS; He XL; Du YA; Chen LC; Hua YW; Huang CM; Xue YW; Zhou Y; Zhou YB; Wu D; Fang XD; Dai YG; Zhang HW; Cao JQ; Li LP; Chai J; Tao KX; Li GL; Jie ZG; Ge J; Xu ZF; Zhang WB; Li QY; Zhao P; Ma ZQ; Yan ZL; Zheng GL; Yan Y; Tang XL; Zhou X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):403-412. PubMed ID: 34000769
    [No Abstract]   [Full Text] [Related]  

  • 17. Association between extent of axillary lymph node dissection and survival in patients with stage I breast cancer.
    Sosa JA; Diener-West M; Gusev Y; Choti MA; Lange JR; Dooley WC; Zeiger MA
    Ann Surg Oncol; 1998 Mar; 5(2):140-9. PubMed ID: 9527267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic characteristics and prognostic factors in 10 783 patients with gastric cancer.
    Kim JP; Lee JH; Kim SJ; Yu HJ; Yang HK
    Gastric Cancer; 1998 Mar; 1(2):125-133. PubMed ID: 11957056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Log odds of positive lymph nodes is prognostically equivalent to lymph node ratio in non-metastatic colon cancer.
    Baqar AR; Wilkins S; Wang W; Oliva K; McMurrick P
    BMC Cancer; 2020 Aug; 20(1):762. PubMed ID: 32795292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemistry-Based Consensus Molecular Subtypes as a Prognostic and Predictive Biomarker for Adjuvant Chemotherapy in Patients with Stage II Colorectal Cancer.
    Li Y; Yao Q; Zhang L; Mo S; Cai S; Huang D; Peng J
    Oncologist; 2020 Dec; 25(12):e1968-e1979. PubMed ID: 32926498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.